205 related articles for article (PubMed ID: 24118272)
1. Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer.
Lai Q; Castro Santa E; Rico Juri JM; Pinheiro RS; Lerut J
Transpl Int; 2014 Jan; 27(1):32-41. PubMed ID: 24118272
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation.
Xia W; Ke Q; Wang Y; Wang W; Zhang M; Shen Y; Wu J; Xu X; Zheng S
World J Surg Oncol; 2015 Feb; 13():60. PubMed ID: 25885777
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil and platelet-to-lymphocyte ratio: new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer?
Tanoglu A; Karagoz E
Transpl Int; 2014 Aug; 27(8):e80-1. PubMed ID: 24612189
[No Abstract] [Full Text] [Related]
4. Reply to 'neutrophil and platelet-to-lymphocyte ratio: new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer?'.
Lai Q; Lerut J
Transpl Int; 2014 Aug; 27(8):e82-3. PubMed ID: 24628991
[No Abstract] [Full Text] [Related]
5. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
[TBL] [Abstract][Full Text] [Related]
6. The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma.
Wang Q; Blank S; Fiel MI; Kadri H; Luan W; Warren L; Zhu A; Deaderick PA; Sarpel U; Labow DM; Hiotis SP
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1125-32. PubMed ID: 26159441
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
Chu MO; Shen CH; Chang TS; Xu HW; Yen CW; Lu SN; Hung CH
Sci Rep; 2018 Nov; 8(1):16611. PubMed ID: 30413724
[TBL] [Abstract][Full Text] [Related]
8. Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver Transplantation.
Ismael MN; Forde J; Milla E; Khan W; Cabrera R
Biomed Res Int; 2019; 2019():7284040. PubMed ID: 31737675
[TBL] [Abstract][Full Text] [Related]
9. Prognostication of inflammatory cells in liver transplantation: Is the waitlist neutrophil-to-lymphocyte ratio really predictive of tumor biology?
McVey JC; Sasaki K; Firl DJ; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Miller CC; Hashimoto K; Aucejo FN
Clin Transplant; 2019 Dec; 33(12):e13743. PubMed ID: 31655000
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
[TBL] [Abstract][Full Text] [Related]
11. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
Xiao GQ; Yang JY; Yan LN
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.
Fan W; Zhang Y; Wang Y; Yao X; Yang J; Li J
PLoS One; 2015; 10(3):e0119312. PubMed ID: 25742141
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria.
Parisi I; Tsochatzis E; Wijewantha H; Rodríguez-Perálvarez M; De Luca L; Manousou P; Fatourou E; Pieri G; Papastergiou V; Davies N; Yu D; Luong T; Dhillon AP; Thorburn D; Patch D; O'Beirne J; Meyer T; Burroughs AK
Liver Transpl; 2014 Nov; 20(11):1327-35. PubMed ID: 25088400
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
16. [Preoperative neutrophil-lymphocyte ratio as a prognostic predictor after liver transplantation for hepatocellular carcinoma].
Wang GY; Yang Y; Zhang Q; Li H; Chen GZ; Yi SH; Xu C; Wang GS; Zhang J; Yi HM; Jiang N; Fu BS; Zhao H; Li MR; Chen YH; Cai CJ; Lu MQ; Chen GH
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1519-22. PubMed ID: 21914362
[TBL] [Abstract][Full Text] [Related]
17. Predictive Models of Hepatocellular Carcinoma Recurrence After Liver Transplantation.
Sánchez Segura J; León Díaz FJ; Pérez Reyes M; Cabañó Muñoz D; Sánchez Pérez B; Pérez Daga JA; Montiel Casado C; Santoyo Santoyo J
Transplant Proc; 2020 Mar; 52(2):546-548. PubMed ID: 32037068
[TBL] [Abstract][Full Text] [Related]
18. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
20. Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.
Zanetto A; Shalaby S; Vitale A; Mescoli C; Ferrarese A; Gambato M; Franceschet E; Germani G; Senzolo M; Romano A; Angeli P; Rugge M; Farinati F; Forton DM; Cillo U; Burra P; Russo FP
Liver Transpl; 2017 Sep; 23(9):1103-1112. PubMed ID: 28544587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]